SCHEMBL17028116

SCHEMBL17028116

O=C(NC1CCC[C@@H]1Nc1cnc(C(F)(F)F)cn1)c1cc(Cl)ccc1-n1nccn1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 20/20 1.00
HCRTR2 O43614 1/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17007292 1.00 HCRTR1 (1.00) HCRTR1HCRTR2
SCHEMBL17007402 0.90 HCRTR1 (1.00) HCRTR1
SCHEMBL22099728 0.90 HCRTR1 (1.00) HCRTR1
SCHEMBL17007153 0.90 HCRTR1 (1.00) HCRTR1HCRTR2
SCHEMBL17007280 0.89 HCRTR1 (1.00) HCRTR1HCRTR2
SCHEMBL22131263 0.89 HCRTR1 (1.00) HCRTR1HCRTR2
SCHEMBL17007305 0.88 HCRTR1 (1.00) HCRTR1
SCHEMBL17028120 0.88 HCRTR1 (1.00) HCRTR1
SCHEMBL17007119 0.88 HCRTR1 (1.00) HCRTR1HCRTR2
SCHEMBL17028112 0.88 HCRTR1 (1.00) HCRTR1HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3107898-A1 1,2-SUBSTITUTED CYCLOPENTANES AS OREXIN RECEPTOR ANTAGONISTS Takeda Pharmaceutical Company Limited (JP) 2016-12-28 EP disclosed
WO-2015124932-A1 1,2-SUBSTITUTED CYCLOPENTANES AS OREXIN RECEPTOR ANTAGONISTS TAKEDA CAMBRIDGE LIMITED (GB) 2015-08-27 WO disclosed